Absci - Public Comps and Valuation Multiples

Absci Overview

About Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Founded

2011

HQ

Employees

157

Website

absci.com

Sectors

Bioinformatics
Drug Development & Therapeutics
BioTech
DeepTech

Financials

LTM Revenue $5.7M

LTM EBITDA -$91.6M

EV

$334M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Absci Financials

As of August 2025, Absci reported last 12-month revenue of $5.7M and EBITDA of -$91.6M.

In the same period, Absci achieved -$109M in LTM net income.

See Absci valuation multiples based on analyst estimates

Absci P&L

In the most recent fiscal year, Absci reported revenue of $4.5M and EBITDA of -$89.1M.

Absci expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Absci valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$5.7M	XXX	$4.5M	XXX	XXX	XXX
Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
Gross Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA	-$91.6M	XXX	-$89.1M	XXX	XXX	XXX
EBITDA Margin	-1611%	XXX	-1965%	XXX	XXX	XXX
EBIT	-$114M	XXX	-$109M	XXX	XXX	XXX
EBIT Margin	-1995%	XXX	-2402%	XXX	XXX	XXX
Net Profit	-$109M	XXX	-$103M	XXX	XXX	XXX
Net Margin	-1921%	XXX	-2274%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Absci including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $5.7M. EBITDA for the last twelve months was -$91.6M. In the most recent fiscal year, Absci achieved $4.5M in revenue and -$89.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$5.7M	Analyst estimates available to subscribers	$4.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	NaN% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$91.6M	Analyst estimates available to subscribers	-$89.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-1610.7% EBITDA margin	Analyst estimates available to subscribers	-1964.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$114M	Analyst estimates available to subscribers	-$109M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-1995.4% EBIT margin	Analyst estimates available to subscribers	-2401.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$109M	Analyst estimates available to subscribers	-$103M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-1921.3% net profit margin	Analyst estimates available to subscribers	-2274.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Absci

This financial data table provides comprehensive performance metrics for Absci, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Absci generated $5.7M in revenue over the last twelve months.
The company achieved -$91.6M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$109M.

Fiscal Year Performance

In the most recent fiscal year, Absci reported $4.5M in total revenue.
Fiscal year EBITDA was -$89.1M.
The company maintained a gross profit margin of NaN% in the most recent fiscal year.
EBITDA margin for the fiscal year was -1964.8%.
Net profit margin reached -2274.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Absci. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Absci Stock Performance

Absci has current market cap of $444M, and EV of $334M.

Market Cap Evolution

Absci Stock Data

As of September 30, 2025, Absci's stock price is $3.

See Absci trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$334M	$444M	XXX	XXX	XXX	XXX	$-0.88

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Absci Valuation Multiples

Absci's trades at 73.7x EV/Revenue multiple, and -3.7x EV/EBITDA.

See valuation multiples for Absci and 15K+ public comps

Absci Financial Valuation Multiples

As of September 30, 2025, Absci has market cap of $444M and EV of $334M.

Equity research analysts estimate Absci's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Absci has a P/E ratio of -4.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$444M	XXX	$444M	XXX	XXX	XXX
EV (current)	$334M	XXX	$334M	XXX	XXX	XXX
EV/Revenue	58.7x	XXX	73.7x	XXX	XXX	XXX
EV/EBITDA	-3.6x	XXX	-3.7x	XXX	XXX	XXX
EV/EBIT	-2.9x	XXX	-3.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-4.1x	XXX	-4.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-4.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Absci Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Absci Margins & Growth Rates

Absci's last 12 month revenue growth is 285%

Absci's revenue per employee in the last FY averaged $29K, while opex per employee averaged $0.7M for the same period.

Absci's rule of 40 is -1384% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Absci's rule of X is -898% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Absci and other 15K+ public comps

Absci Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	285%	XXX	145%	XXX	XXX	XXX
EBITDA Margin	-1611%	XXX	-1965%	XXX	XXX	XXX
EBITDA Growth	-18%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-1384%	XXX	-1679%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-898%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$29K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1408%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	2502%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial